UCCELLI, Licia
 Distribuzione geografica
Continente #
NA - Nord America 13.588
AS - Asia 7.402
EU - Europa 5.395
SA - Sud America 1.436
AF - Africa 154
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 6
Totale 28.020
Nazione #
US - Stati Uniti d'America 13.220
SG - Singapore 2.993
CN - Cina 2.096
IT - Italia 1.448
BR - Brasile 1.216
DE - Germania 781
HK - Hong Kong 703
UA - Ucraina 673
PL - Polonia 629
GB - Regno Unito 550
VN - Vietnam 464
TR - Turchia 450
FI - Finlandia 345
SE - Svezia 242
RU - Federazione Russa 204
CA - Canada 174
MX - Messico 166
IN - India 139
ID - Indonesia 130
FR - Francia 92
ZA - Sudafrica 86
NL - Olanda 83
JP - Giappone 81
AR - Argentina 71
BE - Belgio 64
BD - Bangladesh 63
ES - Italia 57
AT - Austria 53
IR - Iran 46
LT - Lituania 43
IQ - Iraq 40
EC - Ecuador 38
AU - Australia 34
CO - Colombia 29
CZ - Repubblica Ceca 27
VE - Venezuela 27
CH - Svizzera 26
KR - Corea 21
CL - Cile 20
BG - Bulgaria 18
UZ - Uzbekistan 18
MY - Malesia 17
TW - Taiwan 17
MA - Marocco 16
EG - Egitto 14
AE - Emirati Arabi Uniti 13
HU - Ungheria 13
PK - Pakistan 13
RO - Romania 12
SA - Arabia Saudita 12
IL - Israele 11
PY - Paraguay 11
JO - Giordania 10
TH - Thailandia 10
AZ - Azerbaigian 9
BO - Bolivia 8
PT - Portogallo 8
KE - Kenya 7
KG - Kirghizistan 7
UY - Uruguay 7
LB - Libano 6
DK - Danimarca 5
EU - Europa 5
TN - Tunisia 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GY - Guiana 4
IE - Irlanda 4
LV - Lettonia 4
PE - Perù 4
BN - Brunei Darussalam 3
DZ - Algeria 3
HN - Honduras 3
KZ - Kazakistan 3
MK - Macedonia 3
NG - Nigeria 3
NP - Nepal 3
OM - Oman 3
PH - Filippine 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AO - Angola 2
CG - Congo 2
CI - Costa d'Avorio 2
CU - Cuba 2
CY - Cipro 2
GA - Gabon 2
GR - Grecia 2
GT - Guatemala 2
KW - Kuwait 2
LK - Sri Lanka 2
MN - Mongolia 2
MU - Mauritius 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
TV - Tuvalu 2
Totale 27.994
Città #
Singapore 1.662
Ashburn 1.334
Woodbridge 1.068
Fairfield 921
Chandler 805
Houston 763
Jacksonville 719
Santa Clara 700
Beijing 694
Hong Kong 693
Ann Arbor 686
Warsaw 617
Wilmington 380
Ferrara 345
Seattle 334
Dallas 319
Los Angeles 279
Cambridge 264
Nanjing 260
Izmir 257
New York 247
Munich 220
Addison 194
Princeton 181
The Dalles 175
Milan 151
Ho Chi Minh City 143
São Paulo 130
Boardman 128
Mexico City 107
Helsinki 105
Shanghai 105
Dearborn 99
Turku 90
Hanoi 87
San Diego 86
Jakarta 83
Dong Ket 81
Buffalo 74
Shenyang 73
Tokyo 69
Bologna 68
Nanchang 67
Brooklyn 63
London 62
Tianjin 62
Rome 59
Bremen 58
Chicago 57
Redwood City 55
Brussels 54
Hefei 54
Montreal 54
Denver 53
Johannesburg 50
Changsha 49
Chennai 48
Hebei 48
Boston 47
Stockholm 46
Nuremberg 45
Orem 45
Toronto 45
Phoenix 41
Poplar 40
Moscow 39
Rio de Janeiro 39
Falls Church 35
Atlanta 34
Frankfurt am Main 33
Jiaxing 32
San Francisco 31
Vienna 30
Jinan 29
Amsterdam 28
Ankara 28
Kunming 27
Augusta 26
Council Bluffs 26
Brasília 25
Reggio Nell'emilia 25
San Mateo 25
Mountain View 24
Auburn Hills 23
Falkenstein 23
Belo Horizonte 22
Manchester 21
Monmouth Junction 21
Ningbo 21
Legnaro 20
Chengdu 19
Curitiba 19
Querétaro 19
Washington 19
Brno 18
Columbus 18
Guangzhou 18
Porto Alegre 18
Wuhan 18
Des Moines 17
Totale 17.868
Nome #
In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals 466
14 MeV neutrons for 99Mo/99mTc production: Experiments, simulations and perspectives 353
Preclinical SPECT-CT imaging studies with cyclotron produced Tc-99m 293
Proactive Implementation of Quantitative Analysis of the Risk FMEA / FMECA in Nuclear Medicine Procedures 291
Sterilità e asepsi: metodologie, convalide e verifiche 283
Biodistribution of nanostructured lipid carriers: a tomographic study 278
Molecular imaging for the evaluation of drug-–receptor interactions in psycoactive substances of abuse 277
188Re(V) nitrido radiopharmaceuticals for radionuclide therapy 275
Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008-2018) (vol 24, 640, 2019) 254
E-learning as a tool to harmonize education and good quality assurance system in radiopharmacy 240
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 239
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 238
A solvent-extraction module for cyclotron production of high-purity technetium-99m 224
Convalida del processo in asepsi(test Media Fill): preparazioni ottenute a mezzo kit 222
A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma 216
Brain perfusion SPET and proton magnetic resonance spectroscopy in the evaluation of two systemic lupus erythematosus patients with mild neuropsychiatric manifestations 216
YAP-(S)PET small animal scanner: Quantitative results 215
Influence of Storage Temperature on Radiochemical Purity of 99mTc-Radiopharmaceuticals 212
An alternative approach to the preparation of (188)Re radiopharmaceuticals from generator-produced [(188)ReO(4)]:(-) efficient synthesis of (188)Re(V)-meso-2,3-dimercaptosuccinic acid 204
Remotely controlled solvent extraction of high purity Tc-99m produced by conventional medical cyclotrons 204
A new solvent-extraction module for a local routine production of technetium-99m by medical cyclotrons 203
Therapeutic Radiometals: Global Trends Analysis of Scientific Literature (2008 -2018) 191
Sampling considerations for high resolution small animal SPECT 190
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 186
68 Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients 186
Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma 184
Therapeutic radiometals: Worldwide scientific literature trend analysis (2008–2018) 183
A novel approach to the high-specific-activity labeling of small peptides with the technetium-99m fragment [Tc-99m(N) (PXP)](2+) (PXP = diphosphine ligand) 182
Development of an Automatic Separation/Extraction Module for the Accelerator 99mTc Production from 100Mo-Enriched Molybdenum Metal Targets 179
Geometrically controlled selective formation of nitrido technetium(V) asymmetrical heterocomplexes with bidentate ligands 178
Tc(IV)Cl4(PPh3)2 and Tc(III)Cl3(CH3CN)(PPh3)2 as precursors of trans dioxo technetium(V) complexes with chelating amines and tetraazamacrocycles 177
Whole-Body Biodistribution and Radiation Dosimetry of the New Cardiac Tracer 99mTc-N-DBODC 175
Fractionation of radiopharmaceuticals: set-up and verification of an automatic system portable with integrated dose calibrator 175
Development of a β-spectrometer Based on TDCR Method for 99gTc Activity Estimations 174
A small animal hybrid PET-SPECT scanner: First in-vivo results. 173
Labeling of Fatty Acid Ligands with the Strong Electrophilic Metal Fragment [99mTc(N)(PNP)]2+ (PNP=Diphosphane Ligand) 172
A Study on the Gamma-Ray Background of the Images Obtained Using Accelerator- Produced 99mTc 171
Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons 170
Nitrido-technetium and -rhenium Complexes with Chelating Phosphines: Synthesis, Reactivity and Crystal Structures 170
First evaluation in humans of the new myocardial perfusion imaging agent 99mTcN-dbodc: safety, biodistribution and dosimetry assessment 169
Design and synthesis of a redox-active Tc-99m radiopharmaceutical with ferrocenedithiocarboxylate [FcCS = Fe(C5H4CS2)(C5H5)-] 169
Technetium complexes with ligands of pharmacological interest 168
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 167
First Accelerator-Based 99mTc GBq Production Levels and in-vivo Imaging Tests for APOTEMA Experiment 166
90 Y/177 Lu‐dotatoc From Preclinical Studies to Application in Humans 166
Erratum: A kit formulation for the preparation of 188Re- lipiodol: Preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma (Nuclear Medicine Communication (2004) 25 (691-699)) 165
Synthesis of a novel class of nitrido Tc-99m radiopharmaceuticals with phosphino-thiol ligands showing transient heart uptake 164
Performance evaluation of the fully engineered YAP-(S)PET scanner for small animal imaging 163
Technetium-99m sestamibi leg scintigraphy for non-invasive assessment of propionyl-L-carnitine induced changes in skeletal muscle metabolism 163
Imaging of the scrotum: beyond sonography 161
Co-ordination chemistry of S-methyl 2-methyldithiocarbazate and formation of [M≡N]2+(M = Tc or Re) species 160
Mixed tridentate π-donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals 160
Interdisciplinary tasks in the cyclotron production of radiometals for medical applications. The case of 47Sc as example 160
Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate Adenocarcinoma 159
Chemistry of the strong electrophilic metal fragment [99Tc(N)(PXP)]2+ (PXP = diphosphine ligand). A novel tool for the selective labeling of small molecules 159
Extraction techniques of 99mTc from 100Mo Metal Target 159
Automated synthesis of 68Ga-DOTA-TOC with a cationic purification system: Evaluation of methodological and technical aspects in routine preparations 159
Development of new 99mTc-labeled bisphosphonates for bone scintigraphy 157
18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready? 154
Radiochemical purity and stability of 99mTc-HMPAO preparations:the influence of pH, volume recovery, and storage conditions 153
Radioisotopic purity and imaging properties of cyclotron-produced 99mTc using direct100Mo(p,2n) reaction 153
Rolling in the Deep: Imaging Findings and Diagnostic Pearls in Gallstone Ileus 151
Influence of the Generator in-Growth Time on the Final Radiochemical Purity and Stability of Radiopharmaceuticals 150
99Tc≡N/ 99mTc≡N-complexes with aminoacids, synthesis, and crystal structure of [ 99TcNCl (CYS-OEt) (PPh 3)] 148
Safety profile, biodistribution and dosimetry of the new myocardial perfusion imaging agent [99mTc]N.DBODC: first evaluation in Human. 147
Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy 147
Dosimetry of 177Lu-PSMA-617 after mannitol infusion and glutamate tablet administration: Preliminary results of EUDRACT/RSO 2016-002732-32 IRST protocol 147
Comprehensive theoretical investigation of the accelerator-produced 99mTc: determination of post-EOB evolution of quality parameters 146
A remotely controlled module for an in-hospital routine production of Tc-99m by medical cyclotrons 146
Technetium-99m nitrido radiopharmaceuticals with unprecedented biological properties 145
Produzione e verifiche di qualità dei radiofarmaci prodotti mediante kit 145
Radiochemical purity and stability of 99mTc-HMPAO in routine preparations 144
Synthesis and characterization of nitrido Tc(V) and Re(V) complexes with ferrocenedithiocarboxylate {FcCS(2)=[Fe(C5H4CS2)(C5H5)](-)} 142
A Comparison of Separation and Purification Strategies for 51/52Mn cyclotron production 142
Technetium and rhenium heterocomplexes containing the diphenylphosphinoferrocenyl fragment 141
Development of a β-spectrometer for 99gTc Activity Estimations 141
Coordination chemistry of S-methyl,N-methyldithiocarbazate and formation of [M≡N]2+ (M = Tc, Re) species. 140
Underestimation of regional myocardial perfusion with Tc-99m sestamibi single-day rest/stress SPECT: a “drug washout” pitfall? 140
Asymmetrical nitrido Tc-99m heterocomplexes: A class of cardiac agents with unprecedented imaging properties. 138
Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules 137
Technetium complexes and radiopharmaceuticals with scorpionate ligands 137
Labeling and biodistribution studies of Tc-99m radiopharmaceuticals with (o-hydroxyphenyl)diphenylphosphine 136
Rhenium(V) and Technetium(V) Nitrido Complexes with Mixed 2 Tridentate pigreco-Donor and Monodentate pigreco-Acceptor Ligands 136
Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties 136
PEGylated N-methyl-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of nitrido Tc-99m and Re-188 radiopharmaceuticals 135
CYCLOTRON-BASED ALTERNATIVE PRODUCTION OF 99mTc: INFN RESEARCH ACTIVITIES 134
MONTE CARLO SIMULATIONS IN RADIO-LIGAND THERAPY WITH LU-177 FOR NEUROENDOCRINE TUMOURS (NETS) 133
Evaluation of 99Mo and 99mTc Productions Based on a High-Performance Cyclotron 133
Synthesis, solution-state and solid-state structural characterization of monocationic nitrido heterocomplexes [M(N)(DTC(PNP)](+) (M=Tc-99, Re; DTC = dithiocarbamate; PNP = heterodiphosphane) 133
Worldwide ten-year trend analysis of the scientific literature on therapeutic radiometals (2008-2018) 131
A class of asymmetrical nitrido Tc-99m heterocomplexes as heart imaging agents with improved biological properties 131
Incorporation of a glucose moiety in a technetium-99m nitrido compound 130
Advances in radiopharmaceuticals for cardiac imaging: 99mTcN-NOET 129
BIODISTRIBUTION IN MAN OF BIS [(N-ETHYL, N-ETHOXY) DITHIOCARBAMATE] NITRIDO TECHNETIUM-(V), A PROMISING NEW TRACER FOR MYOCARDIAL PERFUSION IMAGING 128
Radiochemical Puritiy Of 99mTc-HMPAO: some Considerations on Routine Radiopharmaceuticals Preparation 128
The Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review 127
UPTAKE MECHANISM OF THE NEUTRAL MYOCARDIAL IMAGING AGENT TC-99MN-NOET 127
Methodology and technical implementation of a procedure for automated production 68Ga-DOTATOC 126
The IART approach: new Re-188 nitrido biotinilated radiopharmaceuticals useful for cancer therapy 124
An alternative method to produce isotopes for medical applications in the framework of the SPES Project: Mo-99 from the UCx target 124
Totale 17.528
Categoria #
all - tutte 131.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 10.472
Totale 141.914


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.557 0 0 0 0 0 237 100 306 88 324 322 180
2021/20222.016 82 164 132 106 115 82 109 109 82 159 274 602
2022/20231.927 218 153 51 231 275 273 103 179 209 24 136 75
2023/20241.348 100 129 140 49 89 187 70 98 48 41 73 324
2024/20255.796 175 170 414 235 618 389 265 326 887 687 1.051 579
2025/20267.870 1.387 563 1.248 1.957 2.251 464 0 0 0 0 0 0
Totale 28.433